Literature DB >> 8826472

Frequency of Fra X syndrome among institutionalized mentally retarded males in Poland.

T Mazurczak1, E Bocian, M Milewski, E Obersztyn, H Stańczak, J Bal, K Szamotulska, M W Karwacki.   

Abstract

Results of cytogenetic studies, performed in a group of 201 institutionalized mentally retarded males, are presented. At least two cytogenetic methods for eliciting the Xq27.3 fragile site, recommended by the Fourth International Workshop on the Fra X Syndrome were used. A subgroup of 67 out of 201 studied males was also examined using molecular methods. In 6 (2.9%) males fra X syndrome was diagnosed. All cytogenetic positive results were confirmed by molecular analysis. Five patients had full expansion CGG repeats and one had both premutation and full mutation. Postulated frequency of fra X syndrome in Polish population being 0.2-0.4/1,000 males seems to be lower than it could be expected on the basis of previous literature data.

Entities:  

Mesh:

Year:  1996        PMID: 8826472     DOI: 10.1002/(SICI)1096-8628(19960712)64:1<184::AID-AJMG32>3.0.CO;2-H

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  4 in total

1.  Molecular evidence that fragile X syndrome occurs in the South African black population.

Authors:  A Goldman; T Jenkins; A Krause
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

Review 2.  Fragile X syndrome: the FMR1 CGG repeat distribution among world populations.

Authors:  Emmanuel Peprah
Journal:  Ann Hum Genet       Date:  2011-12-21       Impact factor: 1.670

Review 3.  FMR1 and the fragile X syndrome: human genome epidemiology review.

Authors:  D C Crawford; J M Acuña; S L Sherman
Journal:  Genet Med       Date:  2001 Sep-Oct       Impact factor: 8.822

4.  Towards a Better Molecular Diagnosis of FMR1-Related Disorders-A Multiyear Experience from a Reference Lab.

Authors:  Sylwia Olimpia Rzońca; Monika Gos; Daniel Szopa; Danuta Sielska-Rotblum; Aleksandra Landowska; Agnieszka Szpecht-Potocka; Michał Milewski; Jolanta Czekajska; Anna Abramowicz; Ewa Obersztyn; Dorota Maciejko; Tadeusz Mazurczak; Jerzy Bal
Journal:  Genes (Basel)       Date:  2016-09-02       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.